Prescription drug · NDA
Celexa (citalopram) NDC 0456-4020
Citalopram hydrobromide 20 mg/1 · Tablet, Film coated · Oral · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0456-4020-01 | 00456402001 | 100 TABLET, FILM COATED in 1 BOTTLE (0456-4020-01)Marketed from Jul 17, 1998 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Celexa
- Generic name (nonproprietary)
- citalopram
- Active ingredients
- Citalopram hydrobromide — 20 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Allergan, Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020822
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 0456-4020_7a584cdb-dfe3-4360-a36d-7e8b93d7d7dbSPL ID 7a584cdb-dfe3-4360-a36d-7e8b93d7d7dbSPL set ID 4259d9b1-de34-43a4-85a8-41dd214e9177RxCUI 200371, 213344, 213345, 283672, 284591, 309314UNII I1E9D14F36UPC 0304564010018, 0304564020017, 0304564040015
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400456402001followed by a unit qualifier and the quantityPackage 00456-4020-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
CELEXA is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )] . CELEXA is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ).
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 020822
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.